Market Tracker

05/22 5:16pm ET

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

3.96
Delayed Data
As of 4:03pm ET
 -0.14 / -3.41%
Today’s Change
1.27
Today|||52-Week Range
7.10
+179.07%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close4.10
Today’s open4.03
Day’s range3.83 - 4.05
Volume302,908
Average volume (3 months)590,176
Market cap$104.2M
Dividend yield--
Data as of 4:03pm ET, 05/22/2017

Growth & Valuation

Earnings growth (last year)+50.00%
Earnings growth (this year)-182.50%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.71

Competitors

 Today’s
change
Today’s
% change
AGRXAgile Therapeutics I...-0.03-0.89%
ALIMAlimera Sciences Inc-0.05-3.33%
AGTCApplied Genetic Tech...+0.15+2.86%
ADMPAdamis Pharmaceutica...+0.05+1.28%
Data as of 3:59pm ET, 05/22/2017

Financials

Next reporting dateAugust 16, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$0.00
Annual profit (last year)-$9.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Peter David Suzdak
Chief Financial Officer, Secretary &
Senior VP
Tae Heum Jeong
Corporate headquarters
Rockville, Maryland

Forecasts